SCHEMBL3402161

SCHEMBL3402161

C=C(C)C(=O)Oc1ccc(OS(=O)(=O)Oc2ccc(O)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 4/20 0.50
KMT2A Q03164 3/20 0.47
ATM Q13315 1/20 0.47
MAPT P10636 5/20 0.39
PKM P14618 2/20 0.39
POLB P06746 2/20 0.39
GAA P10253 3/20 0.38
STS P08842 1/20 0.37
PREP P48147 2/20 0.35
LMNA P02545 2/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
XBP1 P17861 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
THRB P10828 1/20 0.33
BLM P54132 1/20 0.33
CASP6 P55212 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL72362 0.88 ELANE (0.61) ELANEKMT2AATMMAPTGAA
SCHEMBL7202624 0.84 ELANE (0.62) ELANEKMT2AATMMAPTPKM
SCHEMBL217004 0.83 ELANE (0.56) ELANEKMT2AATMMAPTGAA
Methacrylic Acid SCHEMBL8512987 0.83 ELANE (0.60) ELANEKMT2AATMMAPTPOLB
SCHEMBL27243146 0.81 ELANE (0.54) ELANEKMT2AATMMAPTPKM
SCHEMBL56436 0.80 ELANE (0.69) ELANEKMT2AATMMAPTPKM
SCHEMBL19985115 0.80 ELANE (0.76) ELANEKMT2AATMMAPTPKM
Hydroquinone SCHEMBL28395727 0.79 ELANE (0.64) ELANEKMT2AATMMAPTPOLB
SCHEMBL18815812 0.78 MEN1 (0.50) ELANEKMT2AMAPTPKMGAA
SCHEMBL587543 0.77 ESR1 (0.52) ELANEKMT2AATMMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8808960-B2 Compound and chemically amplified positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-08-19 US disclosed
US-20100233628-A1 COMPOUND AND CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100233628-A1 COMPOUND AND CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION HRH3, C9, H1-2 ELANE 2803/4885KMT2A 666/4885ATM 2632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.